NCI
Get informed when a big investor buys or sells
+ FollowOvervalued by 188.6% based on the discounted cash flow analysis.
| Market cap | $5.13 Million |
|---|---|
| Enterprise Value | $53.15 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.65 |
| Beta | -3.18 |
| Outstanding Shares | 508,000 |
| P/E Ratio | -27.93 |
|---|---|
| PEG | 9.34 |
| Price to Sales | 0.04 |
| Price to Book Ratio | 0.09 |
| Enterprise Value to Revenue | 0.46 |
| Enterprise Value to EBIT | 32.03 |
| Enterprise Value to Net Income | -132 |
| Total Debt to Enterprise | 0.95 |
| Debt to Equity | 0.89 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data